Defining Access By Design in R&D For Diagnostics, Therapeutics, And Vaccines

‘This session will reflect on the WHO’s renewed pathogen family strategy, discussing how researchers and organizations can strengthen a collaborative and equitable approach at national, regional and global levels. It will identify potential gaps, what collaborations already exist, and what new actions need to be taken so that the world can expand access to scientific and technological tools for researchers around the world and enable equitable access.’

• Moderator: Saul Walker, Interim Executive Director of Policy, Partnerships and Access, CEPI
• Ana Maria Henao-Restrepo, Lead R&D Blueprint for Epidemics, WHO
• Sue Ann Costa Clemens, Professor of Global Health and Vaccinology at the University of Oxford and the University of Siena
• Charles Gore, Executive Director, Medicines Patent Pool
• Andrea Vicari, Unit Chief Epidemic and Pandemic Preparedness and Response, PAHO
• Melanie Saville, Chief Scientific Officer, PATH
• Jorge Bermudez, Senior Professor at the National School of Public Health; Advisor to the Fiocruz Vice-presidency; PAHO/WHO International Consultant; Member of the MCTI National Science and Technology Council